Opportunities and Challenges Associated with Developing Additional Indications for Clinical Development Candidates and Marketed Drugs
- Donald E. Frail
- , Michael J. Barratt
Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
7
Link opens in a new tab
Scopus
citations